Cargando…
Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of ty...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804856/ https://www.ncbi.nlm.nih.gov/pubmed/35876840 http://dx.doi.org/10.1002/anie.202207175 |
_version_ | 1784862208277086208 |
---|---|
author | Stazzoni, Samuele Böhmer, Daniel F. R. Hernichel, Fabian Özdemir, Dilara Pappa, Aikaterini Drexler, David Bauernfried, Stefan Witte, Gregor Wagner, Mirko Veth, Simon Hopfner, Karl‐Peter Hornung, Veit König, Lars M. Carell, Thomas |
author_facet | Stazzoni, Samuele Böhmer, Daniel F. R. Hernichel, Fabian Özdemir, Dilara Pappa, Aikaterini Drexler, David Bauernfried, Stefan Witte, Gregor Wagner, Mirko Veth, Simon Hopfner, Karl‐Peter Hornung, Veit König, Lars M. Carell, Thomas |
author_sort | Stazzoni, Samuele |
collection | PubMed |
description | 2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of type I interferons and cytokines. The development of STING‐binding molecules with both agonistic as well as antagonistic properties is currently of tremendous interest to induce or enhance antitumor or antiviral immunity on the one hand, or to treat autoimmune diseases on the other hand. To escape the host innate immune recognition, some viruses encode poxin endonucleases that cleave 2′,3′‐cGAMP. Here we report that dideoxy‐2′,3′‐cGAMP (1) and analogs thereof, which lack the secondary ribose‐OH groups, form a group of poxin‐stable STING agonists. Despite their reduced affinity to STING, particularly the compound constructed from two A nucleosides, dideoxy‐2′,3′‐cAAMP (2), features an unusually high antitumor response in mice. |
format | Online Article Text |
id | pubmed-9804856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98048562023-01-06 Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists Stazzoni, Samuele Böhmer, Daniel F. R. Hernichel, Fabian Özdemir, Dilara Pappa, Aikaterini Drexler, David Bauernfried, Stefan Witte, Gregor Wagner, Mirko Veth, Simon Hopfner, Karl‐Peter Hornung, Veit König, Lars M. Carell, Thomas Angew Chem Int Ed Engl Communications 2′,3′‐cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of type I interferons and cytokines. The development of STING‐binding molecules with both agonistic as well as antagonistic properties is currently of tremendous interest to induce or enhance antitumor or antiviral immunity on the one hand, or to treat autoimmune diseases on the other hand. To escape the host innate immune recognition, some viruses encode poxin endonucleases that cleave 2′,3′‐cGAMP. Here we report that dideoxy‐2′,3′‐cGAMP (1) and analogs thereof, which lack the secondary ribose‐OH groups, form a group of poxin‐stable STING agonists. Despite their reduced affinity to STING, particularly the compound constructed from two A nucleosides, dideoxy‐2′,3′‐cAAMP (2), features an unusually high antitumor response in mice. John Wiley and Sons Inc. 2022-08-31 2022-10-04 /pmc/articles/PMC9804856/ /pubmed/35876840 http://dx.doi.org/10.1002/anie.202207175 Text en © 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Communications Stazzoni, Samuele Böhmer, Daniel F. R. Hernichel, Fabian Özdemir, Dilara Pappa, Aikaterini Drexler, David Bauernfried, Stefan Witte, Gregor Wagner, Mirko Veth, Simon Hopfner, Karl‐Peter Hornung, Veit König, Lars M. Carell, Thomas Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title | Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title_full | Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title_fullStr | Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title_full_unstemmed | Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title_short | Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists |
title_sort | novel poxin stable cgamp‐derivatives are remarkable sting agonists |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804856/ https://www.ncbi.nlm.nih.gov/pubmed/35876840 http://dx.doi.org/10.1002/anie.202207175 |
work_keys_str_mv | AT stazzonisamuele novelpoxinstablecgampderivativesareremarkablestingagonists AT bohmerdanielfr novelpoxinstablecgampderivativesareremarkablestingagonists AT hernichelfabian novelpoxinstablecgampderivativesareremarkablestingagonists AT ozdemirdilara novelpoxinstablecgampderivativesareremarkablestingagonists AT pappaaikaterini novelpoxinstablecgampderivativesareremarkablestingagonists AT drexlerdavid novelpoxinstablecgampderivativesareremarkablestingagonists AT bauernfriedstefan novelpoxinstablecgampderivativesareremarkablestingagonists AT wittegregor novelpoxinstablecgampderivativesareremarkablestingagonists AT wagnermirko novelpoxinstablecgampderivativesareremarkablestingagonists AT vethsimon novelpoxinstablecgampderivativesareremarkablestingagonists AT hopfnerkarlpeter novelpoxinstablecgampderivativesareremarkablestingagonists AT hornungveit novelpoxinstablecgampderivativesareremarkablestingagonists AT koniglarsm novelpoxinstablecgampderivativesareremarkablestingagonists AT carellthomas novelpoxinstablecgampderivativesareremarkablestingagonists |